Posted on June 6, 2020 by Sitemaster
Last month, we looked at Level 1 evidence (highest level, superseding all previous studies) that for unfavorable-risk patients, brachy boost therapy (BBT) — i.e., external beam therapy (EBRT) with a brachytherapy boost to the prostate — has better results when accompanied by 18 months of androgen deprivation therapy (ADT) (see this link). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, brachy boost, high, intermediate, radiation, risk, therapy | 3 Comments »
Posted on April 23, 2020 by Sitemaster
For the past few years, some of us have been quietly concerned about the true value of MRI scans and the accuracy of PI-RADS scores in evaluation of a patient’s risk for the presence of clinically significant prostate cancer. This is a complex issue … but data from a large, recently completed study has now validated these concerns. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: MRI, PI-RADS, risk, scan, score | 23 Comments »
Posted on April 22, 2020 by Sitemaster
In a report on the UroToday web site, John Fortin, a prostate cancer patient who chose to have focal therapy himself a while ago, has reported on information presented at the 12th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer, which was held in Washington, DC, in February this year. … READ MORE …
Filed under: Uncategorized | Tagged: focal, localized, risk, therapy | 1 Comment »
Posted on February 5, 2020 by Sitemaster
As the Democratic Party discovered this week in Iowa, apps can have problems. However, there are also apps that prove to be very useful straight out of the gate — and they can be improved over time too. … READ MORE …
Filed under: Diagnosis | Tagged: app, FamGenix, health, predict, risk | Leave a comment »
Posted on November 20, 2019 by Sitemaster
There have long been suggestions that men already diagnosed with and receiving treatment for diabetes are at lower risk for a subsequent diagnosis of prostate cancer than non-diabetics. However, a very large, new, epidemiological analysis seems to suggest strongly that this may not be the case at all. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: ant-diabetic, diabetes, medication, Prevention, risk | 3 Comments »
Posted on November 19, 2019 by Sitemaster
A newly published paper by Blayer et al. in in the journal Cancer has stated that,
Worldwide, the incidence of prostate cancer has increased in all groups between ages 15 and 40 years and increased globally at a steady rate averaging 2% per year since 1990.
… READ MORE …
Filed under: Diagnosis, Risk | Tagged: age, Diagnosis, risk, youth | 2 Comments »
Posted on September 27, 2019 by Sitemaster
In posting the following commentary, we wish to be VERY clear that, at this time, there is no definitive evidence that there is a causal relationship between male infertility and risk for prostate cancer, but this does appear to be a POSSIBILITY. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: assistaed, Diagnosis, fertility, male, reproduction, risk | Leave a comment »
Posted on September 20, 2019 by Sitemaster
A new paper in Clinical Genitourinary Cancer has provided us with some more detailed information about risk for metastasis in men with recurrent prostate cancer after first-line surgery. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: doubling, Gleason, metastasis, PSA, risk, score, time | 14 Comments »
Posted on September 6, 2019 by Sitemaster
Well, maybe, … at least among men living in in the Miyagi and Ohsaki prefectures, in Japan. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Japan, mushrooms, Prevention, risk | Leave a comment »
Posted on August 2, 2019 by Sitemaster
For several years, Dr. Jelle Barentz in the Netherlands has been a prominent advocate for the idea that we might be able to use imaging methodologies (prostate “manograms”, like breast mammograms for women) to screen for risk of prostate cancer — either along with or instead of PSA testing. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biparametric, Diagnosis, fast, MRI, multiparametric, risk, scan | 2 Comments »
Posted on July 31, 2019 by Sitemaster
Patients who are initially diagnosed with primary Gleason pattern 5 localized prostate cancer (i.e., having Gleason scores of 5 + 5 = 10 and 5 + 4 = 9) are well understood to have very high-risk disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: 5, Gleason, medicine, pattern, precision, risk | 3 Comments »
Posted on July 29, 2019 by Sitemaster
Apparently the US Air Force (USAF) has become concerned that being a fighter pilot may increase risk for a diagnosis of prostate cancer. For those who are interested, here’s a link to the relevant article on the McClatchy news service. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Air Force, pilot, research, risk | 1 Comment »
Posted on July 17, 2019 by Sitemaster
New research data on the epidemiology of advanced prostate cancer here in the US has confirmed something that has long been understood (albeit not previously as well documented). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: access, advanced, edpidemiology, risk | Leave a comment »
Posted on June 30, 2019 by Sitemaster
It is well known that prostate cancer is relatively radio-resistant compared to other kinds of cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, dose lewvel, radiation, risk, salvage | Leave a comment »
Posted on June 26, 2019 by Sitemaster
Your sitemaster has long had concerns about the real value of decision aids in helping men to think about and come to conclusions about controversial issues in the diagnosis and management of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: aids, decision, decision-making, risk, shared | Leave a comment »